Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Phenotyping Alzheimer's disease with blood tests | Synapse

August 5, 2021

Phenotyping Alzheimer's disease with blood tests

Key Points

Key points are not available for this paper at this time.

Abstract

Affordable and accessible tools could be used for screening and therapy monitoring

Mark Helpful

Bookmark

Relay

Cite This Study

Kaj Blennow (Thu,) studied this question.

synapsesocial.com/papers/6a12650eea48cb855a34bed0 https://doi.org/https://doi.org/10.1126/science.abi5208

Mark Helpful

Bookmark

Relay

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease2017 · 82 citations
2High performance plasma amyloid-β biomarkers for Alzheimer’s disease2018 · 1,693 citations
3Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau–Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers2017 · 269 citations
4Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography2018 · 661 citations
5NFL is a marker of treatment response in children with SMA treated with nusinersen2019 · 151 citations